154 related articles for article (PubMed ID: 18372159)
1. Oncostatin M induction of eotaxin-1 expression requires the convergence of PI3'K and ERK1/2 MAPK signal transduction pathways.
Smyth DC; Kerr C; Li Y; Tang D; Richards CD
Cell Signal; 2008 Jun; 20(6):1142-50. PubMed ID: 18372159
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
Tong L; Smyth D; Kerr C; Catterall J; Richards CD
Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice.
Langdon C; Kerr C; Tong L; Richards CD
J Immunol; 2003 Jan; 170(1):548-55. PubMed ID: 12496442
[TBL] [Abstract][Full Text] [Related]
5. The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.
Demyanets S; Kaun C; Rychli K; Rega G; Pfaffenberger S; Afonyushkin T; Bochkov VN; Maurer G; Huber K; Wojta J
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1962-8. PubMed ID: 17604327
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin-M up-regulates VCAM-1 and synergizes with IL-4 in eotaxin expression: involvement of STAT6.
Fritz DK; Kerr C; Tong L; Smyth D; Richards CD
J Immunol; 2006 Apr; 176(7):4352-60. PubMed ID: 16547273
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M-induced IL-6 expression in murine fibroblasts requires the activation of protein kinase Cdelta.
Smyth DC; Kerr C; Richards CD
J Immunol; 2006 Dec; 177(12):8740-7. PubMed ID: 17142776
[TBL] [Abstract][Full Text] [Related]
8. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol-3 kinase-dependent activation of Akt does not correlate with either high mitogenicity or cell migration induced by FGF-1.
Marcinkowska E; Wiedlocha A
Anticancer Res; 2003; 23(5A):4071-7. PubMed ID: 14666721
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
12. [Salidroside via ERK1/2 and PI3K/AKT/mTOR signal pathway induces mouse bone marrow mesenchymal stem cells differentiation into neural cells].
Chen YN; Liu H; Zhao HB; Liu Y; Bai J; Zhu XJ; Wang Y
Yao Xue Xue Bao; 2013 Aug; 48(8):1247-52. PubMed ID: 24187831
[TBL] [Abstract][Full Text] [Related]
13. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
14. Acute activation of Erk1/Erk2 and protein kinase B/akt proceed by independent pathways in multiple cell types.
Chiu D; Ma K; Scott A; Duronio V
FEBS J; 2005 Sep; 272(17):4372-84. PubMed ID: 16128807
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C (PKC)-delta/-epsilon mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin.
Greco S; Storelli C; Marsigliante S
J Endocrinol; 2006 Jan; 188(1):79-89. PubMed ID: 16394177
[TBL] [Abstract][Full Text] [Related]
16. Adropin is a novel regulator of endothelial function.
Lovren F; Pan Y; Quan A; Singh KK; Shukla PC; Gupta M; Al-Omran M; Teoh H; Verma S
Circulation; 2010 Sep; 122(11 Suppl):S185-92. PubMed ID: 20837912
[TBL] [Abstract][Full Text] [Related]
17. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
Ghayad SE; Vendrell JA; Ben Larbi S; Dumontet C; Bieche I; Cohen PA
Int J Cancer; 2010 Jan; 126(2):545-62. PubMed ID: 19609946
[TBL] [Abstract][Full Text] [Related]
18. Short-term modulation of extracellular signal-regulated kinase 1/2 and stress-activated protein kinase/c-Jun NH2-terminal kinase in pancreatic islets by glucose and palmitate: possible involvement of ceramide.
Nogueira TC; Graciano MF; Anhê GF; Curi R; Bordin S; Carpinelli AR
Pancreas; 2009 Jul; 38(5):585-92. PubMed ID: 19295452
[TBL] [Abstract][Full Text] [Related]
19. Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes.
El Mabrouk M; Sylvester J; Zafarullah M
Biochim Biophys Acta; 2007 Mar; 1773(3):309-20. PubMed ID: 17208315
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase/Akt plays a part in tumor necrosis factor-alpha-induced interleukin-6 synthesis in osteoblasts.
Takai S; Tokuda H; Hanai Y; Kozawa O
Horm Metab Res; 2006 Sep; 38(9):563-9. PubMed ID: 16981137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
